Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Sorin bioprosthetic valve with phospholipid reduction treatment receives CE mark

Sorin has received CE mark for its Mitroflow Aortic Pericardial Heart Valve with Phospholipid Reduction Treatment (PRT).

PRT, a proprietary advance treatment, is designed to prevent calcification of the Mitroflow bioprosthetic valve.

PRT can decrease phospholipid content in the pericardial tissue leading to a reduction of calcium uptake in the treated pericardial tissue.

Sorin develops technologies for cardiopulmonary bypass, cardiac rhythm management, and heart valve repair and replacement.